Bio-Rad Laboratories, Inc. (BIO)
Largest Insider Buys in Sector
BIO Stock Price History Chart
BIO Stock Performance
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Insider Activity of Bio-Rad Laboratories, Inc.
Over the last 12 months, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $358,992 worth of Bio-Rad Laboratories, Inc. stock.
On average, over the past 5 years, insiders at Bio-Rad Laboratories, Inc. have bought $0 and sold $6.29M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 500 shares for transaction amount of $109,792 was made by HINCKLEY GREGORY K (director) on 2017‑05‑26.
List of Insider Buy and Sell Transactions, Bio-Rad Laboratories, Inc.
| 2023-12-12 | Sale | EVP, President, CDG | 1,200 0.0042% | $299.16 | $358,992 | +9.96% | ||
| 2023-11-28 | Sale | EVP, GBL Commercial Operations | 642 0.0022% | $305.10 | $195,874 | +5.79% | ||
| 2023-08-30 | Sale | EVP, General Counsel & Sec | 2,350 0.0081% | $395.60 | $929,667 | -20.17% | ||
| 2023-08-23 | Sale | EVP, General Counsel & Sec | 300 0.001% | $384.69 | $115,407 | -17.82% | ||
| 2023-06-15 | Sale | EVP, GBL Commercial Operations | 500 0.0017% | $379.39 | $189,695 | -13.92% | ||
| 2023-06-06 | Sale | SVP, Chief Accounting Officer | 198.35 0.0007% | $368.30 | $73,053 | -11.34% | ||
| 2023-03-08 | Sale | EVP, General Counsel & Sec | 1,746 0.006% | $486.43 | $849,300 | -24.18% | ||
| 2022-11-10 | Sale | SVP, Chief Accounting Officer | 379.38 0.0013% | $421.87 | $160,051 | -6.43% | ||
| 2022-08-05 | Sale | SVP, Chief Accounting Officer | 518 0.0017% | $537.00 | $278,166 | -21.06% | ||
| 2021-11-12 | Sale | Executive Vice President | 4,800 0.016% | $750.05 | $3.6M | -29.26% | ||
| 2021-11-11 | Sale | Executive Vice President | 1,546 0.0052% | $749.00 | $1.16M | -28.86% | ||
| 2021-09-03 | Sale | EVP, Chief Financial Officer | 270 0.0009% | $820.06 | $221,416 | -28.93% | ||
| 2021-09-02 | Sale | EVP, Chief Financial Officer | 540 0.0018% | $828.00 | $447,121 | -29.43% | ||
| 2021-09-01 | Sale | EVP, Chief Operating Officer | 2,000 0.0067% | $813.10 | $1.63M | -28.42% | ||
| 2021-08-26 | Sale | Executive Vice President | 600 0.002% | $792.58 | $475,548 | -26.32% | ||
| 2021-08-09 | Sale | EVP, GBL Commercial Operations | 3,000 0.01% | $754.93 | $2.26M | -19.26% | ||
| 2021-08-04 | Sale | EVP, General Counsel & Sec | 327 0.0011% | $760.26 | $248,605 | -19.02% | ||
| 2021-08-04 | Sale | EVP, Chief Financial Officer | 2,300 0.0076% | $751.84 | $1.73M | -19.02% | ||
| 2021-02-19 | Sale | EVP, General Counsel & Sec | 923.11 0.0021% | $432.07 | $398,851 | +4.93% | ||
| 2020-12-15 | Sale | EVP, GBL Commercial Operations | 374 0.0012% | $580.67 | $217,171 | +9.55% |
Insider Historical Profitability
| WRIGHT DARA | EVP, President, CDG | 1499 0.0053% | $341.49 | 0 | 1 | |
| SCHWARTZ ALICE N | director, 10 percent owner | 1806651 6.4463% | $341.49 | 1 | 2 | <0.0001% |
| SCHWARTZ NORMAN D | Chairman, President, and CEO | 411252 1.4674% | $341.49 | 0 | 3 | |
| GOETZ JOHN | EVP, Chief Operating Officer | 61174 0.2183% | $341.49 | 0 | 9 | |
| BENNETT JAMES | director | 32546 0.1161% | $341.49 | 0 | 3 | |
| Magni Giovanni | EVP, Chief Strategy Officer | 20738 0.074% | $341.49 | 0 | 26 | |
| HERTIA JOHN | Executive Vice President | 18728 0.0668% | $341.49 | 0 | 11 | |
| WADLER SANFORD | VP, General Counsel, Secretary | 11936 0.0426% | $341.49 | 0 | 20 | |
| SCHWARTZ DAVID | Chairman of the Board | 8753 0.0312% | $341.49 | 1 | 0 | <0.0001% |
| Crowley Michael | EVP, GBL Commercial Operations | 6942 0.0248% | $341.49 | 0 | 21 | |
| TSINGOS CHRISTINE A | EVP and CFO | 6683 0.0238% | $341.49 | 0 | 22 | |
| HILLMAN AL | director | 6252 0.0223% | $341.49 | 0 | 1 | |
| CRUTCHFIELD BRADFORD | Executive Vice President | 6023 0.0215% | $341.49 | 0 | 11 | |
| TUMOLO ANNETTE | Executive Vice President | 4593 0.0164% | $341.49 | 0 | 7 | |
| HUTTON RONALD W | Vice President and Treasurer | 4140 0.0148% | $341.49 | 1 | 17 | <0.0001% |
| ERNST TIMOTHY S | EVP, General Counsel & Sec | 2416 0.0086% | $341.49 | 0 | 9 | |
| SCHWARTZ STEVEN D | 10 percent owner | 1818 0.0065% | $341.49 | 0 | 4 | |
| Last Andrew J. | EVP, Chief Operating Officer | 1282 0.0046% | $341.49 | 0 | 1 | |
| SODERBERG SHAWN MARIE | EVP, General Counsel, Sec | 652 0.0023% | $341.49 | 0 | 5 | |
| Hall Shannon | Executive Vice President | 565 0.002% | $341.49 | 0 | 9 | |
| HINCKLEY GREGORY K | director | 500 0.0018% | $341.49 | 1 | 0 | +11% |
| STARK JAMES R | VP, Corporate Controller | 0 0% | $341.49 | 1 | 27 | <0.0001% |
| Daskal Ilan | EVP, Chief Financial Officer | 9 0% | $341.49 | 0 | 3 | |
| RAMALINGAM AJIT | SVP, Chief Accounting Officer | 0 0% | $341.49 | 0 | 3 |
Institutional Investor Ownership
| The Vanguard Group | $837.47M | 8.49 | 2.42M | +1.32% | +$10.88M | 0.02 | |
| BlackRock | $511.85M | 5.19 | 1.48M | +0.93% | +$4.72M | 0.01 | |
| Veritas Asset Management LLP | $396.75M | 4.02 | 1.15M | +5.93% | +$22.21M | 2.88 | |
| State Street | $302.18M | 3.06 | 873,675 | -0.14% | -$428,532.93 | 0.01 | |
| EARNEST Partners | $178.09M | 1.81 | 514,906 | +30.81% | +$41.94M | 0.82 | |
| Select Equity Group, L.P. | $178.01M | 1.8 | 514,666 | +167.47% | +$111.45M | 0.64 | |
| Geode Capital Management | $163.26M | 1.66 | 473,201 | +2.85% | +$4.52M | 0.01 | |
| Invesco | $159.45M | 1.62 | 461,006 | +0.71% | +$1.13M | 0.03 | |
| Ubs Asset Management Americas Inc | $146.01M | 1.48 | 422,157 | -16.11% | -$28.03M | 0.05 | |
| Investec Asset Management UK | $145.47M | 1.48 | 420,600 | New | +$145.47M | 0.41 | |
| TSW (Thompson, Siegel & Walmsley LLC) | $121.06M | 1.23 | 350,014 | +0.44% | +$532,984.16 | 1.87 | |
| Massachusetts Financial Services Co Ma | $120.1M | 1.22 | 347,252 | +7.74% | +$8.63M | 0.04 | |
| Southeastern Asset Management | $118.97M | 1.21 | 343,959 | -5.52% | -$6.95M | 4.57 | |
| Dimensional Fund Advisors | $104.07M | 1.06 | 300,904 | +37.04% | +$28.13M | 0.03 | |
| Hound Partners Llc | $91.5M | 0.93 | 264,537 | +1.1% | +$993,684.51 | 27.27 | |
| Northern Trust | $87.69M | 0.89 | 253,533 | +0.45% | +$393,600.06 | 0.01 | |
| Morgan Stanley | $87.28M | 0.89 | 252,340 | +0.91% | +$784,782.03 | 0.01 | |
| Parnassus Investments Ca | $82.24M | 0.83 | 237,790 | 0% | +$0 | 0.18 | |
| Westfield Capital Management Co Lp | $79.73M | 0.81 | 230,509 | -6.76% | -$5.78M | 0.42 | |
| Charles Schwab | $77.28M | 0.78 | 223,441 | +4.3% | +$3.18M | 0.02 | |
| SEI Investments Company | $64.55M | 0.65 | 186,626 | +18.67% | +$10.16M | 0.1 | |
| Artisan Partners | $62.2M | 0.63 | 179,840 | +18.56% | +$9.74M | 0.09 | |
| Parsifal Capital Management Lp | $61.57M | 0.62 | 178,013 | -7.09% | -$4.7M | 4.25 | |
| Allspring Global Investments | $56.65M | 0.57 | 163,783 | -1.41% | -$810,719.86 | 0.09 | |
| Bellevue Group | $54.17M | 0.55 | 156,618 | +10.96% | +$5.35M | 0.83 | |
| BNY Mellon | $53.73M | 0.55 | 155,360 | +16.01% | +$7.42M | 0.01 | |
| Deerfield Management | $52.7M | 0.53 | 152,378 | +0.53% | +$277,733.61 | 0.13 | |
| Legal & General | $50.9M | 0.52 | 147,160 | -2.94% | -$1.54M | 0.01 | |
| GW&K Investment Management | $47.69M | 0.48 | 137,886 | +0.07% | +$32,166.16 | 0.42 | |
| Mawer Investment Management Ltd | $46.12M | 0.47 | 133,353 | +7.65% | +$3.28M | 0.21 | |
| Qvidtvm Management Llc | $43.56M | 0.44 | 125,938 | +0.72% | +$311,283.00 | 3.09 | |
| Tikvah Management Llc | $40.86M | 0.41 | 118,147 | 0% | +$0 | 8.59 | |
| Nitorum Fund LP | $38.62M | 0.39 | 111,653 | -17.23% | -$8.04M | 3.93 | |
| Deutsche Bank | $36.82M | 0.37 | 106,451 | +15.28% | +$4.88M | 0.02 | |
| Fidelity Investments | $36.38M | 0.37 | 105,193 | -23.59% | -$11.23M | <0.01 | |
| First Pacific Advisors LP | $36.23M | 0.37 | 104,739 | +2,052.47% | +$34.54M | 0.41 | |
| Anchor Capital Advisors LLC | $34.6M | 0.35 | 100,031 | +30.42% | +$8.07M | 0.91 | |
| Southpoint Capital Advisors Lp | $34.59M | 0.35 | 100,000 | New | +$34.59M | 0.68 | |
| Envestnet Asset Management Inc | $34.54M | 0.35 | 99,866 | -2.07% | -$730,478.95 | 0.01 | |
| Grantham Mayo Van Otterloo & Co LLC | $32.29M | 0.33 | 93,352 | -5.79% | -$1.98M | 0.1 | |
| Nuveen | $31.69M | 0.32 | 91,477 | +3.68% | +$1.12M | 0.01 | |
| Portolan Capital Management | $31.47M | 0.32 | 90,992 | +58.87% | +$11.66M | 2.42 | |
| Federated Hermes | $31.19M | 0.32 | 90,183 | +13.45% | +$3.7M | 0.07 | |
| Fisher Asset Management Llc | $28M | 0.28 | 80,943 | +0.35% | +$96,497.73 | 0.01 | |
| The Manufacturers Life Insurance Company | $27.48M | 0.28 | 79,464 | +7.95% | +$2.02M | 0.03 | |
| Marathon Asset Management Limited | $26.24M | 0.27 | 75,857 | New | +$26.24M | 0.7 | |
| Qube Research & Technologies | $25.17M | 0.26 | 72,770 | -57.17% | -$33.6M | 0.03 | |
| Boone Capital Management Llc | $25.02M | 0.25 | 72,344 | +102.57% | +$12.67M | 5.06 | |
| Franklin Templeton Investments | $25.05M | 0.25 | 72,423 | +281.17% | +$18.48M | 0.01 | |
| Point72 Asset Management | $24.7M | 0.25 | 71,400 | New | +$24.7M | 0.04 |